UPDATE 1-Takeda: FDA won't finish diabetes drug review on time - Reuters

« « Don't Diet Alone…Join Calorie Count Plus Groups  |  Older Diabetics With Depression Face Higher Death Rate - Washington Post » »

UPDATE 1-Takeda: FDA won't finish diabetes drug review on time - Reuters

Saturday, October 11th, 2008    Subscribe To Our Feed


Network Médica

UPDATE 1-Takeda: FDA won't finish diabetes drug review on time
Reuters?- 22 hours ago
The drug, called alogliptin or SYR-322, is critical to Takeda's mainstay diabetes business as it is expected to be the main replacement for its best-selling
Diabetes Drug FDA Review Not on Schedule Due to Lack of Resources Network Médica
PPD's payment from Takeda hung up by FDA delay StarNewsOnline.com
FDA Continues Review of Takeda's New Drug Application for MarketWatch
Forbes?- Bizjournals.com
all 47 news articles

Source:UPDATE 1-Takeda: FDA won't finish diabetes drug review on time - Reuters

No Tags

Like this post? Publish It On Your Own Blog
Share and Enjoy:
  • Digg
  • Furl
  • del.icio.us
  • Slashdot
  • Smarking
  • NewsVine
  • SphereIt
  • blinkbits
  • Reddit
  • Blue Dot
  • StumbleUpon
  • BlinkList
  • Spurl
  • Netscape

Leave a Reply

Related Posts from the Past: